William T. Andrews - 02 Jun 2025 Form 3 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role: Chief Medical Officer
Signature: /s/ William T. Andrews
Issuer symbol: CPRX
Transactions as of: 02 Jun 2025
Net transactions value: $0
Form type: 3
Filing time: 06 Jun 2025, 17:00:46 UTC
Previous filing: 19 Nov 2021
Next filing: 24 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Andrews William T.	Chief Medical Officer	355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES	/s/ William T. Andrews	06 Jun 2025	0001638459

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CPRX	Common Stock, par value $0.001 per share						0	02 Jun 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CPRX	Options to purchase common stock							02 Jun 2025	Common Stock	124,447	$24.90	Direct	F1
holding	CPRX	Restricted Stock Units							02 Jun 2025	Common Stock	15,261		Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Derivative Securities vest in five annual tranches beginning on June 2, 2026.
F2	Shares of common stock will be delivered to the Reporting Person upon vesting.
F3	Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.